Role of obesity and adiposity in polycystic ovary syndrome

被引:93
作者
Diamanti-Kandarakis, E. [1 ]
机构
[1] Univ Athens, Sch Med, Dept Internal Med 1, GR-11527 Athens, Greece
关键词
polycystic ovary syndrome; visceral adipocyte; insulin resistance; hyperinsulinaemia;
D O I
10.1038/sj.ijo.0803730
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome ( PCOS) is the most common endocrinopathy in women of reproductive age. Obesity may have a marked impact on both the development and progression of the syndrome. A high proportion of women with PCOS are obese. Regardless of the degree of obesity, women with PCOS are more likely to have central ( abdominal) distribution of body fat, which is associated with insulin resistance and hyperandrogenaemia. PCOS is not only a reproductive disorder, but is also associated with significant increase in metabolic aberrations and cardiovascular risk factors. It has been shown that weight loss improves the metabolic and reproductive abnormalities that characterise the syndrome.
引用
收藏
页码:S8 / S13
页数:6
相关论文
共 40 条
  • [1] Adipose tissue as an endocrine organ
    Ahima, RS
    Flier, JS
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (08) : 327 - 332
  • [2] Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome
    Apridonidze, T
    Essah, PA
    Iuorno, MJ
    Nestler, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) : 1929 - 1935
  • [3] A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain
    Asunción, M
    Calvo, RM
    San Millán, JL
    Sancho, J
    Avila, S
    Escobar-Morreale, HF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) : 2434 - 2438
  • [4] The prevalence and features of the polycystic ovary syndrome in an unselected population
    Azziz, R
    Woods, KS
    Reyna, R
    Key, TJ
    Knochenhauer, ES
    Yildiz, BO
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2745 - 2749
  • [5] Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
    Azziz, Ricardo
    Carmina, Enrico
    Dewailly, Didier
    Diamanti-Kandarakis, Evanthia
    Escobar-Morreale, Hector F.
    Futterweit, Walter
    Janssen, Onno E.
    Legro, Richard S.
    Norman, Robert J.
    Taylor, Ann E.
    Witchel, Selma F.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) : 4237 - 4245
  • [6] Increased C-reactive protein levels in the polycystic ovary syndrome: A marker of cardiovascular disease
    Boulman, N
    Levy, Y
    Leiba, R
    Shachar, S
    Linn, R
    Zinder, O
    Blumenfeld, Z
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) : 2160 - 2165
  • [7] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. FERTILITY AND STERILITY, 2004, 81 (01) : 19 - 25
  • [8] Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives
    Cussons, AJ
    Stuckey, BGA
    Watts, GF
    [J]. ATHEROSCLEROSIS, 2006, 185 (02) : 227 - 239
  • [9] POLYCYSTIC-OVARY-SYNDROME AND RISK FOR MYOCARDIAL-INFARCTION - EVALUATED FROM A RISK FACTOR MODEL BASED ON A PROSPECTIVE POPULATION STUDY OF WOMEN
    DAHLGREN, E
    JANSON, PO
    JOHANSSON, S
    LAPIDUS, L
    ODEN, A
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 (08) : 599 - 604
  • [10] DALE PO, 1992, FERTIL STERIL, V58, P487